Trial intelligence / Profile preview

SOL vs mFOLFOX6 in Untreated Metastatic Colorectal Cancer

NCT00721916Phase 2Completed

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Jul 2008
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur in metastatic colorectal cancer (mCRC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Jul 2008; status: completed.

02

Drugs

tegafur
03

Conditions

metastatic colorectal cancer (mCRC)

Beyond the preview

Go deeper on NCT00721916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00721916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call